Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 4.
doi: 10.1007/s00198-025-07679-8. Online ahead of print.

Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density

Affiliations

Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density

Maarten J Beekman et al. Osteoporos Int. .

Abstract

Women at high familial risk for ovarian cancer are recommended to undergo risk-reducing salpingo-oophorectomy (RRSO), leading to surgical menopause and short-term bone loss. However, long-term studies and osteoporosis screening recommendations are lacking. Eighteen years after premenopausal RRSO, women had lower bone mineral density compared with women who underwent a postmenopausal RRSO.

Purpose: To prevent ovarian cancer, BRCA1/2 germline pathogenic variant carriers are recommended to undergo premenopausal risk-reducing salpingo-oophorectomy (RRSO). Premenopausal RRSO leads to immediate menopause, which has been associated with an acute phase of rapid bone loss. However, data on long-term bone mineral density (BMD) is scarce and inconclusive. We aimed to investigate long-term BMD after premenopausal RRSO.

Methods: We conducted a cross-sectional study nested in a nationwide cohort of women at high familial risk of ovarian cancer. We compared 493 women who underwent premenopausal RRSO (≤ 45 years) with 228 women who underwent postmenopausal RRSO (≥ 54 years). BMD was assessed by Dual-Energy X-ray absorptiometry of the lumbar spine (LS) and femoral neck (FN). Age differences between the pre- and postmenopausal RRSO groups were accounted for using Z-scores.

Results: Median age at study visit was 59.2 years in the premenopausal RRSO group and 69.7 years in the postmenopausal RRSO group (P < 0.001), median time since premenopausal RRSO was 18.1 years (IQR 15.3-21.3). In multivariable regression analyses the BMD Z-scores of the LS and FN were significantly lower for the premenopausal compared with the postmenopausal RRSO group (β -0.88, 95% CI, -1.10,-0.66 for LS; β -0.51, 95% CI, -0.71,-0.31 for FN). Relative risks (RRs) of having a Z-score ≤ -1.0 were also higher in the premenopausal compared with the postmenopausal RRSO group (RR 2.35, 95% CI, 1.26-4.40 and RR 1.84, 95% CI, 1.08-3.13, respectively).

Conclusion: Premenopausal RRSO appears to be associated with long-term lowering of BMD Z-scores, emphasizing the importance of counseling women about bone health after premenopausal RRSO.

Clinical trial registration: The pre-registered clinical trial number is < NCT03835793 > .

Keywords: Bone Mineral Density; DXA; Early Menopause; Epidemiology; Estrogen.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: This study was conducted according to the standards of Good Clinical Practice, in agreement with the principles of the Declaration of Helsinki and with the Dutch law as stated in the Medical Research Involving Human Subjects Act (WMO). The study has been approved in writing by the Institutional Review Board of the AVL/NKI to be conducted in all nine University Medical Centers and the Antoni van Leeuwenhoek. Consent to participate: All participants included in this study signed informed consent. Conflict of interest: MB, LT, AS, BH, JR, MvB, LvD, JdH, EvD, CM, BS, CM, RS, MS, MS, HV, BdK, CK, KG, KvE, LvdK, MC, MW, MA, LB, EG, CvA, MH, AM, MM, FvL and CZ declare that they have no conflict of interest.

References

    1. Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM et al (2021) Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19(1):77–102 - DOI - PubMed
    1. Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975 - DOI - PubMed - PMC
    1. McKinlay SM (1996) The normal menopause transition: an overview. Maturitas 23(2):137–145 - DOI - PubMed
    1. Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80–87 - DOI - PubMed - PMC
    1. Jones AR, Enticott J, Ebeling PR, Mishra GD, Teede HT, Vincent AJ (2024) Bone health in women with premature ovarian insufficiency/early menopause: a 23-year longitudinal analysis. Hum Reprod 39(5):1013–1022 - DOI - PubMed - PMC

Associated data

LinkOut - more resources